SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-20-000003
Filing Date
2020-02-12
Accepted
2020-02-12 12:11:34
Documents
81
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20191231x10q.htm 10-Q 1208257
2 EX-31.1 veru-20191231xex31_1.htm EX-31.1 15574
3 EX-31.2 veru-20191231xex31_2.htm EX-31.2 15852
4 EX-32.1 veru-20191231xex32_1.htm EX-32.1 11574
  Complete submission text file 0000863894-20-000003.txt   6555918

Data Files

Seq Description Document Type Size
5 EX-101.INS veru-20191231.xml EX-101.INS 1452594
6 EX-101.SCH veru-20191231.xsd EX-101.SCH 63961
7 EX-101.CAL veru-20191231_cal.xml EX-101.CAL 85868
8 EX-101.DEF veru-20191231_def.xml EX-101.DEF 179228
9 EX-101.LAB veru-20191231_lab.xml EX-101.LAB 464644
10 EX-101.PRE veru-20191231_pre.xml EX-101.PRE 380161
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 20602510
SIC: 2834 Pharmaceutical Preparations